Cytopenias Could Represent an Early Marker of Cancer Mortality Risk
According to findings from the REGARDS trial, peripheral blood cytopenias may be associated with a higher risk of cancer-related mortality, particularly in Black patients. These findings suggest that cytopenia may be an early marker of severe disease, according to the study authors. The report was shared at the 2021 ASH Annual Meeting. REGARDS included 30,239 U.S. individuals who were followed with a semiannual phone interview through 2018 for cytopenia and cancer mortality. Investigators calculated the risk of cytopenia-related cancer mortality in three Cox proportional hazards models: ...
Advertisement
Advertisement